Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Mar 18, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-03-18$0.09/sh+1,000$90→ 3,137,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-16$0.08/sh+1,000$80→ 3,135,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-16$0.09/sh+1,000$90→ 3,136,073 total